Nang Kuang Pharmaceutical Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Nang Kuang Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 31.35 TWD -1.1% Market Closed

Market Cap: NT$3.2B

N	Nang Kuang Pharmaceutical Co Ltd TWSE:1752	TW
A	Aeon Thana Sinsap Thailand PCL SET:AEONTS	TH
R	Rusta AB (publ) STO:RUSTA	SE
	Wells Fargo & Co NYSE:WFC	US
	Magnis Energy Technologies Ltd ASX:MNS	AU
A	Allstate Corp XETRA:ALS	US
V	Visa Inc SWB:3V64	US
S	Salim Ivomas Pratama Tbk PT SWB:2IR	ID
E	Encompass Health Corp SWB:HSOA	US
H	Hewlett Packard Enterprise Co SWB:2HP	US
	SEGRO PLC LSE:SGRO	UK
S	Steel Dynamics Inc XMUN:SD5	US
D	Dampskibsselskabet Norden A/S SWB:D69	DK
T	Toyota Tsusho Corp SWB:9TO	JP

Profitability Summary

Nang Kuang Pharmaceutical Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

36%

Sustainable 3Y Average Gross Margin

36%

Declining Gross Margin

36% > 36%

Healthy Operating Margin

14%

Sustainable 3Y Average Operating Margin

15%

Declining Operating Margin

17% > 14%

Healthy Net Margin

11%

Sustainable 3Y Average Net Margin

12%

Declining Net Margin

19% > 11%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

19% > 8%

Low ROE

10%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.